Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1995-06-06
2000-03-14
Scheiner, Laurie
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
4241881, 4242081, C12N 700
Patent
active
06037165&
ABSTRACT:
Methods for producing the newly discovered HIV-2 retrovirus and its antigens are provided. The antigens are obtained from various HIV-2 retroviruses. The antigen compositions comprise a lysate of an HIV-2 retrovirus, a protein of an HIV-2 retrovirus, or a glycoprotein of an HIV-2 retrovirus. Specifically, the antigen composition can comprise p12, p16, p26, gp32, gp42, and gp140.
REFERENCES:
patent: 4839288 (1989-06-01), Montagnier et al.
patent: 5066782 (1991-11-01), Montagnier et al.
patent: 5670309 (1997-09-01), Norrby et al.
Stryer, Biochemistry, pp. 761-763 (W.H. Freeman and Company, San Francisco 1975).
Wain-Hobson et al., Nucleotide Sequence of the AIDS Virus, LAV, Cell 40:9-17 (1985).
Clavel et al., Molecular cloning and polymorphism of the human immune deficiency virus type 2, Nature 324:691-695 (1986).
Wang et al., Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein, Proc. Natl. Acad. Sci. USA 83:6159-6163 (1986).
Guyader et al., Genome organization and transactivation of the human immunodeficiency virus type 2, Nature 326:662-669 (1987).
Chakrabarti et al., Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses, Nature 328:543-547 (1987).
Keller et al., Amino Acid Changes in the Fourth Conserved Region of Human Immunodeficiency Virus Type 2 Strain HIV-2 Envelope Glycoprotein Modulate Fusion, J. Virol. 67(10):6253-6258 (1993).
Appendix II:CD Markers in Immunology, 1996, Roitt et al., eds., Mosby, New York, pp. AI-III.
American Type Culture Collection Catalogue of Cell Lines and Hybridomas, Seventh Edition, pages X and 297, 1992.
Goodenow et al., 1989, J. Acquir. Immune Defic. Syndr. 2:344-352.
Holland et al., 1992, Curr. Topics Micro. Immunol. 176:1-19.
Gao et al., 1994, J. Virol. 68:7433-7447.
Alizon Marc
Brun-Vezinet Fran.cedilla.oise
Chamaret Solange
Clavel Fran.cedilla.ois
Guetard Denise
Institut Pasteur
Parkin Jeffrey S.
Scheiner Laurie
LandOfFree
Methods for the preparation of human immunodeficiency virus type does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the preparation of human immunodeficiency virus type, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the preparation of human immunodeficiency virus type will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-168424